4.6 Article

Favorable long-term outcomes of one-year adjuvant S-1 monotherapy for pathological stage II or III gastric cancer treated at a high-volume center

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine

Shinichi Sakuramoto et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)